Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on June 1, 2026

Jun. 1, 2026

BriaCell Presents Positive Clinical Data at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics

Indeterminate GlobeNewswire

Jun. 1, 2026

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Indeterminate GlobeNewswire

Jun. 1, 2026

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Indeterminate GlobeNewswire

Jun. 1, 2026

Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers

Indeterminate GlobeNewswire

Jun. 1, 2026

Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking

Indeterminate GlobeNewswire

Jun. 1, 2026

Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer

Indeterminate GlobeNewswire

Jun. 1, 2026

Verano Announces 1-for-5 Reverse Stock Split to Prepare the Company for Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire

Jun. 1, 2026

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

Indeterminate GlobeNewswire

Jun. 1, 2026

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 1, 2026

Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Indeterminate GlobeNewswire

Jun. 1, 2026

Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

Indeterminate GlobeNewswire

Jun. 1, 2026

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

Indeterminate GlobeNewswire

Jun. 1, 2026

Life Sciences Investment Opportunities Accelerate as AI and Genomics Drive $200+ Billion Market Expansion

Indeterminate GlobeNewswire

Jun. 1, 2026

Human Appeal Releases “Thrive with Dignity” Impact Report, Highlighting Support for Over 7.3 Million People Globally

Indeterminate GlobeNewswire

Jun. 1, 2026

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia

Indeterminate GlobeNewswire

Jun. 1, 2026

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Indeterminate GlobeNewswire

Jun. 1, 2026

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Indeterminate GlobeNewswire